Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy
Authors:
- Raymond PowlesRPRaymond Powles
- Elliot ShinebourneESElliot Shinebourne
- John HamerJHJohn Hamer
Open Access
Abstract
It has been shown in nine asthmatic patients that practolol, a selective cardiac beta-adrenergic antagonist, successfully blocks the unwanted tachycardia and palpitation following isoprenaline inhalation without hindering the beneficial bronchodilator action of the drug. Practolol is a useful adjunct to bronchodilator therapy in the management of bronchial asthma.Keywords
This publication has 7 references indexed in Scilit:
- Haemodynamic Responses to Exercise in Hypertension: Place of the Sympathetic Nervous System Evaluated by a New Selective Cardiac Beta-adrenergic Blocking Agent ICI 50,172Cardiovascular Research, 1968
- Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exerciseBritish Journal of Pharmacology, 1968
- Investigation into use of drugs preceding death from asthma.BMJ, 1968
- Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease.BMJ, 1968
- Effects of I.C.I. 50172 in man during erect exercise.BMJ, 1968
- SELECTIVE BLOCKADE OF ADRENOCEPTIVE BETA RECEPTORS IN THE HEARTBritish Journal of Pharmacology, 1968
- A STUDY OF THE ADRENOTROPIC RECEPTORSAmerican Journal of Physiology-Legacy Content, 1948